Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Allogenic Plasma Aliquots as a Source of Plasminogen in the Treatment of Ligneous Conjunctivitis, Clinical Trial of One Case

NCT04275232 is registered in ClinicalTrials.gov with Dorothy Bautista, MD as lead sponsor.

NCT NCT04275232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04275232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Allogenic Plasma Aliquots as a Source of Plasminogen in the Treatment of Ligneous Conjunctivitis, Clinical Trial of One Case
Lead sponsor
Dorothy Bautista, MD
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
May 31, 2025
Completion date
October 31, 2025
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ligneous conjunctivitis, left eye